Biotronik announced the European market launch of its new Renamic implantable cardiac device programmer. The programmer is used for initial programming, reprogramming and testing of implantable pacemakers, implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices after implantation. By conducting all measurements and adjustments, Renamic helps clinicians to optimise individual patient therapy.
The benefits of Renamic have been confirmed in more than 1000 follow-up user tests. Its new user interface has been optimised with improved use of spacing and an intuitive color coding. The touchscreen can either be used with the stylet-or with any other tool, from fingers to ordinary pens.
Besides being the smallest programming device in its class, Renamic features special compartments for accessories such as the power cord, so they can be stored within the device during transportation.
To ensure maximum compatibility with other systems and technologies, Renamic offers multiple options for data transmission, including Bluetooth, Global System for Mobile Communications (GSM) and wireless LAN (Wi-Fi). Furthermore, Renamic is already prepared to accommodate SafeSync (Biotronik), which allows for wireless interrogation of the implanted cardiac devices.
“In combination with Reocor, our new external pacemaker, and Reliaty, our new pacing system analyser, Renamic completes a rapid succession of brand new external device releases,” stated Marlou Janssen, vice president, Global Marketing and Sales, Cardiac Rhythm Management, Biotronik.
“The new Renamic programmer is the result of intensive collaboration between engineers and clinicians and is optimally suited for the requirements in daily clinic routines,” said Heiner Vontobel, Head cardiologist at Zuercher Oberland Healthcare, Switzerland. “The device’s easy handling and simple programming help to increase my clinic efficiency. Plus, the device’s robust design makes it very reliable.”